Outcomes of COVID-19 in sickle cell disease patients

ABSTRACT

Coronavirus disease 2019 (COVID-19), is an acute respiratory disease that spread widely around the world, causing increased morbidity and mortality. This was a retrospective observational analytical study from April 2020 to August 2021 in admitted COVID19 patients with Sickle Cell Anaemia, in King Saud Medical City. The study aims to evaluate the outcomes of COVID-19 in Sickle Cell Anaemia patients. Analyse the different prognostic factors to identify prognostic factors associated with mortality. The present study is composed of 13 SCD patients (53.8% male's vs 46.2% females) with a mean age of 29 years old. 6 patients (46.2%) had blood transfusions and 2 patients had bilateral infiltration after a chest x-ray. Patients who required intubation were 15.4% (n=2). 69.2% of the patients were being admitted and the median days of the hospital were 6 days. Finally, the primary limitation of this observational study is the few numbers of SCD who had COVID-19, which raises the possibility of type II statistical error due to the lack of power.